Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.70
-0.09 (-0.65%)
At close: Aug 18, 2025, 10:46 AM

Crescent Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025
Period Ending Jun 30, 2025
PE Ratio
n/a
PEG Ratio
n/a
PS Ratio
n/a
PB Ratio
n/a
P/FCF Ratio
n/a
P/OCF Ratio
n/a
OCF/S Ratio
n/a
Debt / Equity Ratio
0.01
Quick Ratio
9.21
Current Ratio
9.21
Asset Turnover
n/a
Interest Coverage
-19.6
Return on Equity
-0.16
Return on Assets
-0.14
Return on Invested Capital
-0.15
Dividend Yield
n/a
Payout Ratio
n/a
Gross Profit Margin
n/a
Net Profit Margin
n/a
Pretax Profit Margin
n/a
Operating Profit Margin
n/a
FCF Margin
n/a
EBITDA Margin
n/a